A Dietary Treatment Improves Cerebral Blood Flow and Brain Connectivity in Aging apoE4 Mice

APOE ε4 (apoE4) polymorphism is the main genetic determinant of sporadic Alzheimer's disease (AD). A dietary approach (Fortasyn) including docosahexaenoic acid, eicosapentaenoic acid, uridine, choline, phospholipids, folic acid, vitamins B12, B6, C, and E, and selenium has been proposed for dietary management of AD. We hypothesize that the diet could inhibit AD-like pathologies in apoE4 mice, specifically cerebrovascular and connectivity impairment. Moreover, we evaluated the diet effect on cerebral blood flow (CBF), functional connectivity (FC), gray/white matter integrity, and postsynaptic density in aging apoE4 mice. At 10–12 months, apoE4 mice did not display prominent pathological differences compared to wild-type (WT) mice. However, 16–18-month-old apoE4 mice revealed reduced CBF and accelerated synaptic loss. The diet increased cortical CBF and amount of synapses and improved white matter integrity and FC in both aging apoE4 and WT mice. We demonstrated that protective mechanisms on vascular and synapse health are enhanced by Fortasyn, independent of apoE genotype. We further showed the efficacy of a multimodal translational approach, including advanced MR neuroimaging, to study dietary intervention on brain structure and function in aging.

[1]  R. Kornowski,et al.  Treatment of aspirin-resistant patients with omega-3 fatty acids versus aspirin dose escalation. , 2010, Journal of the American College of Cardiology.

[2]  B. Vellas,et al.  B-vitamins and fatty acids in the prevention and treatment of Alzheimer's disease and dementia: a systematic review. , 2010, Journal of Alzheimer's disease : JAD.

[3]  S. Strickland,et al.  The APOE ε4/ε4 Genotype Potentiates Vascular Fibrin(Ogen) Deposition in Amyloid-Laden Vessels in the Brains of Alzheimer's Disease Patients , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[4]  Sachin Dixit,et al.  APOE4 Allele Disrupts Resting State fMRI Connectivity in the Absence of Amyloid Plaques or Decreased CSF Aβ42 , 2010, The Journal of Neuroscience.

[5]  P. Scheltens,et al.  Can nutrients prevent or delay onset of Alzheimer's disease? , 2010, Journal of Alzheimer's disease : JAD.

[6]  D. Holtzman,et al.  Apolipoprotein E in Alzheimer's disease and other neurological disorders , 2011, The Lancet Neurology.

[7]  David D Shin,et al.  Interaction of age and APOE genotype on cerebral blood flow at rest. , 2013, Journal of Alzheimer's disease : JAD.

[8]  N. Maeda,et al.  Targeted Replacement of the Mouse Apolipoprotein E Gene with the Common Human APOE3 Allele Enhances Diet-induced Hypercholesterolemia and Atherosclerosis* , 1997, The Journal of Biological Chemistry.

[9]  R. Wurtman,et al.  Use of phosphatide precursors to promote synaptogenesis. , 2009, Annual review of nutrition.

[10]  Valerio Zerbi,et al.  Multinutrient diets improve cerebral perfusion and neuroprotection in a murine model of Alzheimer's disease , 2014, Neurobiology of Aging.

[11]  J. Koistinaho,et al.  Western-type diet modulates inflammatory responses and impairs functional outcome following permanent middle cerebral artery occlusion in aged mice expressing the human apolipoprotein E4 allele , 2013, Journal of Neuroinflammation.

[12]  G. Pascal,et al.  Essentiality of ω3 Fatty Acids for Brain Structure and Function1 , 1991 .

[13]  S. Coons,et al.  Association of amyloid burden, brain atrophy and memory deficits in aged apolipoprotein ε4 mice. , 2014, Current Alzheimer research.

[14]  R. Wurtman,et al.  Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses. , 2010, Nutrition reviews.

[15]  P. Luiten,et al.  Dietary long chain PUFAs differentially affect hippocampal muscarinic 1 and serotonergic 1A receptors in experimental cerebral hypoperfusion , 2002, Brain Research.

[16]  C R Jack,et al.  Serial MRI and CSF biomarkers in normal aging, MCI, and AD , 2010, Neurology.

[17]  K. Garai,et al.  Structural differences between apoE3 and apoE4 may be useful in developing therapeutic agents for Alzheimer’s disease , 2012, Proceedings of the National Academy of Sciences.

[18]  Huaxi Xu,et al.  Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy , 2013, Nature Reviews Neurology.

[19]  J. Rutledge,et al.  The vascular contribution to Alzheimer's disease. , 2010, Clinical science.

[20]  Klaus P. Ebmeier,et al.  The APOE ɛ4 allele modulates brain white matter integrity in healthy adults , 2011, Molecular Psychiatry.

[21]  D. Lütjohann,et al.  Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  ichard,et al.  FISH CONSUMPTION AND THE 30-YEAR RISK OF FATAL MYOCARDIAL INFARCTION , 2000 .

[23]  B. Zlokovic Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders , 2011, Nature Reviews Neuroscience.

[24]  R. Mahley,et al.  Apolipoprotein E: far more than a lipid transport protein. , 2000, Annual review of genomics and human genetics.

[25]  Yaakov Stern,et al.  Mediterranean diet and risk for Alzheimer's disease , 2006, Annals of neurology.

[26]  Thomas Espeseth,et al.  APOE-related biomarker profiles in non-pathological aging and early phases of Alzheimer's disease , 2013, Neuroscience & Biobehavioral Reviews.

[27]  John J Sidtis,et al.  Abnormal white matter integrity in healthy apolipoprotein E epsilon4 carriers , 2005, Neuroreport.

[28]  Yaakov Stern,et al.  Mediterranean diet and Alzheimer disease mortality , 2007, Neurology.

[29]  L. Joosten,et al.  Effects of Specific Multi-Nutrient Enriched Diets on Cerebral Metabolism, Cognition and Neuropathology in AβPPswe-PS1dE9 Mice , 2013, PloS one.

[30]  B. Zlokovic Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease. , 2013, JAMA neurology.

[31]  P. Barberger‐Gateau,et al.  Relationship between diet and plasma long-chain n-3 PUFAs in older people: impact of apolipoprotein E genotype , 2013, Journal of Lipid Research.

[32]  Victoria J. Bourne,et al.  n–3 Fatty acid erythrocyte membrane content, APOE ε4, and cognitive variation: an observational follow-up study in late adulthood , 2008 .

[33]  John A. Detre,et al.  Arterial spin labeled MRI in prodromal Alzheimer's disease: A multi-site study☆ , 2013, NeuroImage: Clinical.

[34]  D. Holtzman,et al.  The Role of Apolipoprotein E in Alzheimer's Disease , 2009, Neuron.

[35]  P. G. Reeves,et al.  AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. , 1993, The Journal of nutrition.

[36]  P. Calder,et al.  Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. , 2010, Atherosclerosis.

[37]  R. Wurtman,et al.  Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils , 2007, Neuroscience.

[38]  George E. Marzloff,et al.  Synaptic proteins and phospholipids are increased in gerbil brain by administering uridine plus docosahexaenoic acid orally , 2006, Brain Research.

[39]  R J Havel,et al.  Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. , 1982, Journal of lipid research.

[40]  Jesse A. Brown,et al.  Brain network local interconnectivity loss in aging APOE-4 allele carriers , 2011, Proceedings of the National Academy of Sciences.

[41]  J. O’Keefe,et al.  Omega-3 fatty acids for cardioprotection. , 2008, Mayo Clinic proceedings.

[42]  Verena Heise,et al.  Apolipoprotein E genotype, gender and age modulate connectivity of the hippocampus in healthy adults , 2014, NeuroImage.

[43]  Masahiko Watanabe,et al.  Apo E structure determines VLDL clearance and atherosclerosis risk in mice. , 1999, The Journal of clinical investigation.

[44]  Mikael Fogelholm,et al.  Faculty of 1000 evaluation for Primary prevention of cardiovascular disease with a Mediterranean diet. , 2013 .

[45]  R. Sperling,et al.  Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline , 2010, Neurology.

[46]  P. Kamphuis,et al.  Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination. , 2013, Journal of Alzheimer's disease : JAD.

[47]  R. Mahley,et al.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[48]  J. O’Keefe,et al.  Fish oil in primary and secondary cardiovascular prevention. , 2008, The Ochsner journal.

[49]  Cornelis J. Stam,et al.  The Effect of Souvenaid on Functional Brain Network Organisation in Patients with Mild Alzheimer’s Disease: A Randomised Controlled Study , 2014, PloS one.

[50]  G. Pascal,et al.  Essentiality of omega 3 fatty acids for brain structure and function. , 1991, World review of nutrition and dietetics.

[51]  C. Jack,et al.  Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers , 2013, The Lancet Neurology.

[52]  Cornelis J Stam,et al.  Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. , 2012, Journal of Alzheimer's disease : JAD.

[53]  Valerio Zerbi,et al.  Resting-State Functional Connectivity Changes in Aging apoE4 and apoE-KO Mice , 2014, The Journal of Neuroscience.

[54]  A. Dale,et al.  Higher Rates of Decline for Women and Apolipoprotein E ε4 Carriers , 2013, American Journal of Neuroradiology.

[55]  C. Sudlow,et al.  APOE associations with severe CAA-associated vasculopathic changes: collaborative meta-analysis , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[56]  P. Dederen,et al.  Impact of a multi-nutrient diet on cognition, brain metabolism, hemodynamics, and plasticity in apoE4 carrier and apoE knockout mice , 2013, Brain Structure and Function.

[57]  A. Dyer,et al.  Fish consumption and the 30-year risk of fatal myocardial infarction. , 1997, The New England journal of medicine.

[58]  L. Westlye,et al.  Effects of APOE on brain white matter microstructure in healthy adults , 2012, Neurology.

[59]  J M Guileyardo,et al.  cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[60]  M. Chiariello,et al.  Omega-3 polyunsaturated fatty acid in peripheral arterial disease: effect on lipid pattern, disease severity, inflammation profile, and endothelial function. , 2008, Clinical nutrition.

[61]  R. Honea,et al.  Impact of APOE on the healthy aging brain: a voxel-based MRI and DTI study. , 2009, Journal of Alzheimer's disease : JAD.

[62]  Y. Stern,et al.  Imaging studies and APOE genotype in persons at risk for Alzheimer’s disease , 1996, Current psychiatry reports.

[63]  Marcel P. Zwiers,et al.  Patching cardiac and head motion artefacts in diffusion-weighted images , 2010, NeuroImage.

[64]  Prashanthi Vemuri,et al.  Effect of APOE ε4 status on intrinsic network connectivity in cognitively normal elderly subjects. , 2011, Archives of neurology.

[65]  R. Kornowski,et al.  Treatment of aspirin-resistant patients with omega-3 fatty acids versus aspirin dose escalation. , 2010, Journal of the American College of Cardiology.

[66]  D. Lütjohann,et al.  Importance of a Novel Oxidative Mechanism for Elimination of Brain Cholesterol , 1997, The Journal of Biological Chemistry.

[67]  T. Bayer,et al.  Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain DOI 10.1194/jlr.M200071-JLR200 , 2002, Journal of Lipid Research.

[68]  A. Garthe,et al.  Improved spatial learning strategy and memory in aged Alzheimer AβPPswe/PS1dE9 mice on a multi-nutrient diet. , 2013, Journal of Alzheimer's disease : JAD.

[69]  D. Grobbee,et al.  Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials , 2002, Journal of hypertension.

[70]  E. Irle,et al.  Serum 24S-hydroxycholesterol and hippocampal size in middle-aged normal individuals , 2009, Neurobiology of Aging.

[71]  J. Manson,et al.  Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. , 2002, JAMA.

[72]  T. A. Carpenter,et al.  Voxel-based morphometry in the R6/2 transgenic mouse reveals differences between genotypes not seen with manual 2D morphometry , 2009, Neurobiology of Disease.

[73]  C. Dawczynski,et al.  n-3 LC-PUFA-enriched dairy products are able to reduce cardiovascular risk factors: a double-blind, cross-over study. , 2010, Clinical nutrition.

[74]  Rosanna Abbate,et al.  Adherence to Mediterranean diet and health status: meta-analysis , 2008, BMJ : British Medical Journal.

[75]  C. Jack,et al.  Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease , 2009, Brain : a journal of neurology.

[76]  R. Wurtman,et al.  Oral supplementation with docosahexaenoic acid and uridine-5′-monophosphate increases dendritic spine density in adult gerbil hippocampus , 2007, Brain Research.

[77]  P. Calder,et al.  Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial , 2003, The Lancet.

[78]  P. Scheltens,et al.  Efficacy of a medical food in mild Alzheimer's disease: A randomized, controlled trial , 2010, Alzheimer's & Dementia.

[79]  P. Talmud,et al.  ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[80]  E. P. Kennedy,et al.  The function of cytidine coenzymes in the biosynthesis of phospholipides. , 1956, The Journal of biological chemistry.

[81]  C. Iadecola Neurovascular regulation in the normal brain and in Alzheimer's disease , 2004, Nature Reviews Neuroscience.

[82]  Seong-Gi Kim Quantification of relative cerebral blood flow change by flow‐sensitive alternating inversion recovery (FAIR) technique: Application to functional mapping , 1995, Magnetic resonance in medicine.

[83]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[84]  Jürgen Hennig,et al.  In vivo diffusion tensor magnetic resonance imaging and fiber tracking of the mouse brain , 2010, NMR in biomedicine.

[85]  M. Verhoye,et al.  Functional Connectivity fMRI of the Rodent Brain: Comparison of Functional Connectivity Networks in Rat and Mouse , 2011, PloS one.

[86]  G Durand,et al.  The effects of dietary alpha-linolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats. , 1989, The Journal of nutrition.

[87]  W. Harris,et al.  Cardiovascular benefits of omega-3 fatty acids. , 2007, Cardiovascular research.